Correlation Between BioAffinity Technologies and Aspira Womens

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Aspira Womens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Aspira Womens into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies Warrant and Aspira Womens Health, you can compare the effects of market volatilities on BioAffinity Technologies and Aspira Womens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Aspira Womens. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Aspira Womens.

Diversification Opportunities for BioAffinity Technologies and Aspira Womens

0.14

Correlation Coefficient

BioAffinity Technologies  Aspira Womens

Average diversification

The 3 months correlation between BioAffinity and Aspira is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Aspira Womens Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aspira Womens Health and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Aspira Womens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aspira Womens Health has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Aspira Womens go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Aspira Womens

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to generate 3.42 times more return on investment than Aspira Womens. However, BioAffinity Technologies is 3.42 times more volatile than Aspira Womens Health. It trades about 0.03 of its potential returns per unit of risk. Aspira Womens Health is currently generating about -0.01 per unit of risk. If you would invest  117.00  in bioAffinity Technologies Warrant on September 2, 2024 and sell it today you would lose (45.00) from holding bioAffinity Technologies Warrant or give up 38.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

bioAffinity Technologies Warra  vs.  Aspira Womens Health

BioAffinity Technologies

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Aspira Womens Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aspira Womens Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Aspira Womens is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with BioAffinity Technologies and Aspira Womens

The main advantage of trading using opposite BioAffinity Technologies and Aspira Womens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Aspira Womens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womens will offset losses from the drop in Aspira Womens' long position.

The idea behind bioAffinity Technologies Warrant and Aspira Womens Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.